Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBQLN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NOTCH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDRGK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABIF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PALLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LYPLAL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLAA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INTS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LUC7L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMT12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMNA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM64 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on